The effect of adiponectin on metastasis was first described in 2009, where several research groups showed that adiponectin inhibits the adhesion, migration, and invasion of breast cancer cells mainly by increasing the expression of LKB1, a tumor-suppressor gene that activates the AMPK–S6K axis [80,81]. Here, ADIPOQ is linked to breast cancer.